Results of Annual General Meeting of Shareholders Held May 31, 2018
?Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF - the Company), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing an...
Insights into the latest developments in CDMO services and manufacturing.
Continue readingExpert perspectives on the evolving needs of injectable therapies and packaging.
Continue readingExploring the latest developments in inhalation technologies, respiratory delivery and sustainability
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement